Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Glioblastoma × Disulfiram × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 6 Radiotherapy 6 Bevacizumab 4 Magnetic Resonance Spectroscopy 3 olaparib 2 fluorodopa F 18 2 fluciclovine F-18 2 abemaciclib 2 Specimen Handling 2 Radiation 2 Everolimus 2 Carvedilol 2 zimberelimab 1 temsirolimus 1 senicapoc 1 sacituzumab govitecan 1 ribociclib 1 posaconazole 1 pitavastatin 1 perampanel 1 pamiparib 1 palbociclib 1 niraparib 1 mycophenolic adenine dinucleotide 1 lorlatinib 1 ixazomib 1 infigratinib 1 fimepinostat 1 evolocumab 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03151772 2020-09-28

INSIDE

Sahlgrenska University Hospital

Phase EARLY_PHASE1 Terminated

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡